Table 2.
Surveillance ultrasound target population |
• Inclusion: |
◦ Adults with cirrhosis of any cause |
◦ Subsets of adult patients with chronic HBV infection, even in the absence of cirrhosis |
◦ Asian male hepatitis B carriers over age 40 years |
◦ Asian female hepatitis B carriers over age 50 years |
◦ Hepatitis B carrier with family history of HCC |
◦ African or North American blacks with hepatitis B |
• Exclusion: |
◦ Child–Pugh C cirrhosis, unless patient is a transplant candidate |
• Population in which benefit of surveillance is uncertain: |
◦ Adults with NASH but without cirrhosis |
◦ Adults with chronic hepatitis C without cirrhosis |
|
Diagnostic population for LI-RADS (CT, MRI, and CEUS) |
• Inclusion: |
◦ Adults with cirrhosis |
◦ Chronic hepatitis B |
◦ Current or prior HCC including adult liver transplantation candidates and patients posttransplant |
• Exclusion: |
◦ Cirrhosis due to vascular disorder or congenital hepatic fibrosis |
◦ Pediatric patients |
Notes: Target populations for screening and surveillance and target population for diagnostic imaging with CT, MRI, or CEUS. Guidelines based on the American Association for Study of Liver Diseases (AASLD).1
Abbreviations: CEUS, contrast-enhanced ultrasound; HCC, hepatocellular carcinoma; HPV, hepatitis B virus; LI-RADS, Liver Imaging Reporting and Data System; NASH, nonalcoholic steatohepatitis.